Key Points
Covishield, the Covid-19 vaccine developed by UK-based drug major AstraZeneca and Oxford University and produced in India by Serum Institute of India, has triggered a big controversy in India with political parties too jumping in..
There are demands for compensation for family members of people who died allegedly due to the vaccine side effects and to review the science behind all Covid vaccines...
AstraZeneca is contesting the claims but has accepted, in a legal document submitted to the high court in February, that its Covid vaccine can, in very rare cases, cause thrombosis with thrombocytopenia syndrome, which causes people to have blood clots and a low blood platelet count...
Former Indian Council of Medical Research (ICMR) scientist R Ganga Ketkar, who was at the helm of affairs during the Covid pandemic, said symptoms of TTS - a serious adverse event that causes blood clots - can only occur within five to 30 days of receiving a Covid vaccine and not now..
Amid the controversy over the side effects of the AstraZeneca vaccine, Bharat Biotech has asserted that its Covid-19 vaccine, Covaxin, is safe and devoid of any side-effects The company stated that Covaxin was developed with a single-minded focus on safety first, followed by efficacy..
